Literature DB >> 20487307

Nogo-A expression in oligodendroglial tumors.

Tae-Young Jung1, Shin Jung, Kyung-Hwa Lee, Van Thang Cao, Shu-Guang Jin, Kyung-Sub Moon, In-Young Kim, Sam-Suk Kang, Hyung-Seok Kim, Min-Cheol Lee.   

Abstract

Nogo-A belongs to the reticulon protein family and is expressed in the inner and outer loops of myelin sheaths of oligodendrocytes. We analyzed the patterns of Nogo-A expression in human gliomas in an effort to identify a useful marker for the characterization of oligodendroglial tumors. We determined the expression of Nogo-A in a panel of 58 astrocytic and oligodendroglial tumors using immunohistochemistry and compared the expression of Nogo-A with Olig-2, a recently identified marker for oligodendrogliomas. To localize Nogo-A expression, immunofluorescent staining was performed using other glial markers (MAP-2 and GFAP). We also confirmed the overexpression of the Nogo-A protein in 53 astrocytic and oligodendroglial tumors using Western blot analysis. Based on immunohistochemical analysis, Nogo-A and Olig-2 had specificity in the detection of oligodendroglial tumors from astrocytic tumors (P=0.001). The level of Nogo-A staining was highly correlated with Olig-2 (P=0.001). The sensitivity and specificity of Nogo-A for oligodendroglial tumors was 86.9% and 57.1%, respectively. Nogo-A expression overlapped that of other oligodendroglial markers, but with different patterns of expression. Western blot analysis revealed that Nogo-A is predominantly expressed in 85.7% of oligodendroglioma cells and 93.7% of anaplastic oligodendroglioma cells. Like other oligodendroglial markers, Nogo-A is highly expressed in oligodendroglial tumors; however, it does not serve as a definite marker specific for oligodendroglial tumors.
© 2010 Japanese Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20487307     DOI: 10.1111/j.1440-1789.2010.01118.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  6 in total

1.  Prognosis of oligodendroglial tumor with ring enhancement showing central necrotic portion.

Authors:  Ki-Young Choi; Tae-Young Jung; Shin Jung; Young-Hee Kim; Kyung-Sub Moon; In-Young Kim; Sam-Suk Kang; Kyung-Hwa Lee
Journal:  J Neurooncol       Date:  2010-08-25       Impact factor: 4.130

2.  Nogo-C contributes to HCC tumorigenesis via suppressing cell growth and its interactome analysis with comparative proteomics research.

Authors:  Xing Liu; Shu-Jian Cui; Shi-Jun Zhu; De-Chun Geng; Long Yu
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

3.  Association of genetic variations in RTN4 3'-UTR with risk of uterine leiomyomas.

Authors:  Kui Zhang; Peng Bai; Shaoqing Shi; Bin Zhou; Yanyun Wang; Yaping Song; Li Rao; Lin Zhang
Journal:  Pathol Oncol Res       Date:  2013-03-12       Impact factor: 3.201

4.  A Nogo-Like Signaling Perspective from Birth to Adulthood and in Old Age: Brain Expression Patterns of Ligands, Receptors and Modulators.

Authors:  Gabriella Smedfors; Lars Olson; Tobias E Karlsson
Journal:  Front Mol Neurosci       Date:  2018-02-19       Impact factor: 5.639

5.  The isoform A of reticulon-4 (Nogo-A) in cerebrospinal fluid of primary brain tumor patients: influencing factors.

Authors:  Olga Martyna Koper; Joanna Kamińska; Anna Milewska; Karol Sawicki; Zenon Mariak; Halina Kemona; Joanna Matowicka-Karna
Journal:  Oncotarget       Date:  2018-05-18

6.  Myelin-associated proteins are potential diagnostic markers in patients with primary brain tumour.

Authors:  Olga M Koper-Lenkiewicz; Anna J Milewska; Joanna Kamińska; Karol Sawicki; Robert Chrzanowski; Justyna Zińczuk; Joanna Reszeć; Marzena Tylicka; Ewa Matuszczak; Joanna Matowicka-Karna; Zenon Mariak; Mariusz W Mucha; Robert Pawlak; Violetta Dymicka-Piekarska
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.